Leukemia Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
-
Technologybased in Paramus, NEW JERSEY (USA)
Starton is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer. Focused on continuous ...
Model STAR-LLD - Chronic Lymphocytic Leukemia (Cll)
STAR-LLD is in development in two continuous delivery systems: subcutaneous and transdermal. STAR-LLD is being developed to establish the only IMiD (immunomodulatory drug) approved for CLL. CLL is the most common form of leukemia. ...
CONTACT SUPPLIER -
Service providerbased in New Haven, CONNECTICUT (USA)
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer ...
Acute Myeloid Leukemia Panel
Precipio’s HemeScreen acute myeloid leukemia AML Panel offerings are in vitro diagnostic assays that screen for clinically actionable somatic mutations in targets of interest related to AML. This Research Use Only (RUO) assay ...
CONTACT SUPPLIER -
Manufacturerbased in South San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Model SENTI-202 - Acute Myeloid Leukemia Cells
Pursuing an Unmet Need in the Treatment of AML - SENTI-202 is designed to target and eliminate acute myeloid leukemia cells while sparing healthy bone marrow. Our vision is a potential medicine that does not rely on an invasive bone ...
CONTACT SUPPLIER -
Manufacturerbased in Woodland Hills, CALIFORNIA (USA)
EntroGen offers end-to-end molecular diagnostic solutions by providing hardware, reagents and software. Starting from automated nucleic acid extraction and culminating in genomic interpretation with proprietary software embedded for key decision ...
Leukemia Fusion Gene One-Step Detection Kits
Many hematologic malignancies carry characteristic chromosomal translocations believed to play an important role in the pathogenesis of these tumors. Chromosomal translocations found in leukemias and lymphomas either fuse ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Pascal Biosciences Inc. (TSXV:PAS, FSE:6PB.F) is a biopharmaceutical company founded in 2013 to advance technology licensed from the University of British Columbia. We create additional value with programs licensed from other organizations and with ...
Pascal - Model Pre-BCR - Antibodies for Leukemia
B cell precursor acute lymphoblastic leukemia (BCP-ALL or ALL) is a challenging hematologic malignancy with significant unmet medical need. More than 6000 patients are diagnosed with ALL each year in the US and Canada. About half of ...
CONTACT SUPPLIER -
Manufacturerbased in NEW YORK (USA)
'Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug ...
Creative BioMart - Model LIF-22H - Recombinant Human Leukemia Inhibitory Factor
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
Eutilex - Model EU301(MVR CAR-T) - Relapsed and Refractory B Cell Leukemia and B Cell Lymphoma
MVR CAR-T can be used against HLA-DR positive cancer, as well as B cell malignancy. The epitopes recognized by HLA-DR are not shed or internalized, enabling stable binding to human lymphoma cells. MVR CAR-T can also be used in patients who relapse ...
CONTACT SUPPLIER -
Technologybased in New York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
Stemline - Model CD123 - Multiple Malignancies
CD123 is expressed on multiple malignancies including BPDCN, AML, certain myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), B-cell acute lymphoid leukemia (B-ALL), ...
CONTACT SUPPLIER -
Manufacturerbased in London, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
CDX Bi-specific Antibodies for Patient Conditioning
-specific antibodies that redirect patients’ own immune cells to eliminate HSC. In addition, CDX antibodies show promise in efficiently eliminating malignant cells belonging to a subset of leukemia. In sum, CDX antibodies have ...
CONTACT SUPPLIER -
Manufacturerbased in Palo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program
Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid ...
CONTACT SUPPLIER -
Technologybased in Cambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Sumitomo - Model DSP-5336 - Menin-MLL Binding Inhibitor
DSP-5336 is a small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein. Menin is a scaffold nuclear protein that plays various key roles in biological pathways, including cell growth regulation, ...
CONTACT SUPPLIER -
Manufacturerbased in Mont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
Manufacturing Science Services
the past few years in implementing multiple chemistry, manufacturing, and control (CMC) amendments associated with our CAR T programs, including our proprietary OptimAb manufacturing process for our autologous acute myeloid ...
CONTACT SUPPLIER -
Manufacturerbased in Mountain View, CALIFORNIA (USA)
Chronus Health, a Fogarty Innovation company, develops in-vitro point-of-care devices leveraging microfluidics and semiconductor technologies with a mission to reduce time-to-care and improve patient outcomes. Chronus Health's portable platform is ...
-
Manufacturerbased in New York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
DeltEx Allo - Model INB-100 - Allogeneic Product
INB-100, our DeltEx Allo, is an allogeneic product candidate, initially developed for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation (HSCT). This is the first clinical trial of an ...
CONTACT SUPPLIER -
Manufacturerbased in Utrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
Lava - Model 051 - Pipeline
Our lead program, LAVA-051, is a unique, humanized gamma-delta bsTCE targeting CD1d-expressing tumors, including multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). We have ...
CONTACT SUPPLIER -
Technologybased in Cambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
Hematopoietic Stem Cell Transplant Treatment
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this ...
CONTACT SUPPLIER -
Law firmbased in Wilmington, NORTH CAROLINA (USA)
Law firm representing plaintiffs in personal injury and wrongful death lawsuits involving products liability and workers' compensation claims concerning unsafe drugs, harmful chemicals, and asbestos-related cancers or ...
-
Manufacturerbased in Tokyo, JAPAN
The innovative technology of “Bio 3D Printing” by Cyfuse was created through a deft fusion of the latest insights and technologies in the disparate fields of biology and engineering. Cyfuse is working toward the creation of “hope” for novel ...
-
Manufacturerbased in Tampere, FINLAND
Injeq IQ-Tip products are designed and manufactured to meet the requirements of the European Medical Device Regulation (MDR 2017/745). As a medical device manufacturer, Injeq applies standard ISO 13485:2016 in its quality system. IQ-Tip needle ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you